Healio

Healio.com is a valuable resource designed for healthcare professionals, allowing you to customize and access news and educational content that aligns with your medical practice. This comprehensive clinical information platform provides top-notch news coverage, engaging multimedia, Q&A sections, continuing medical education (CME) opportunities, and various educational formats. You can also find quick reference materials, insightful blogs, peer-reviewed journals, and a wide selection of popular books. Created by SLACK Incorporated, a forward-thinking healthcare communications company based in Thorofare, NJ, Healio.com delivers a thorough and enriching content experience for its users.

International, Trade/B2B

English

Online/Digital

Outlet metrics

Domain Authority

Ranking

Global

#63194

United States

#20669

Health/Health

#493

Traffic sources

Monthly visitors

Articles

Study: ADHD meds unlikely to cause psychotic experiences in kids

22 hours ago | healio.com | Sara Kellner

There have been recurring reports of psychotic events, such as hallucinations and delusions, in relation to treatment with stimulant medications such as methylphenidate and amphetamines for decades, with an uncertain relationship continuing despite long investigation. This study looked at a large sample of over 8,000 children aged 9 to 14 years old who were followed for 1 year in the Adolescent Brain Cognitive Development longitudinal study (2016-2020) across 21 research sites.
CeraVe, Neutrogena ranked best over-the-counter products by US News

23 hours ago | healio.com | Gabrielle Capaldo

Key takeaways: A panel of dermatologists selected their top recommended brands for the Best Over-The-Counter Medicine & Health Products list. La Roche Posay also climbed the rankings this year. CeraVe and Neutrogena over-the-counter products topped the U.S. News & World Report third annual Best OTC Medicine & Health Products list for the second consecutive year, according to a press release.
5,000 daily steps linked to ‘drastic decreases’ in mortality for women cancer survivors

1 day ago | healio.com | Matthew Shinkle

Key takeaways: Maximal mortality benefit was observed for 5,000 to 6,000 steps per day and 60 minutes per day of moderate to vigorous physical activity. Every 102.2 minutes of sitting per day was linked to higher mortality risk. More daily steps and less sedentary behavior were associated with reduced risk for all-cause and cardiovascular disease mortality among postmenopausal cancer survivors.
US stops recommending chikungunya vaccine for people 60 and older

1 day ago | healio.com | Stephen Feller

This pause parallels another live arboviral vaccine, yellow fever, where there is a precaution for people aged 60 years or older. No other live-attenuated vaccines are currently in routine use in this age cohort in the United States. Immunosenescence affects older persons’ ability to adequately control replication of all live attenuated vaccine viruses.
Icotrokinra demonstrates high rates of clearance in scalp, genital psoriasis

1 day ago | healio.com | Gabrielle Capaldo

Key takeaways: Icotrokinra showed rapid efficacy among adults and adolescents with at least moderate psoriasis. Most participants with scalp psoriasis treated with icotrokinra achieved the study’s primary endpoint. Icotrokinra demonstrated high rates of clearance in scalp and genital psoriasis after 16 weeks of treatment, according to data presented at the 2025 Society for Investigative Dermatology Annual Meeting.
‘Dilution is the solution to pollution’ of online misinformation about cancer

2 days ago | healio.com | Jennifer Southall

Key takeaways: Misinformation was more persuasive when shared by clinicians, despite many not licensed in urology or oncology. Physicians should provide trusted sources of information to reduce misinformation exposure. There is a continued need for physicians to provide patients with an “information prescription” to counteract exposure to online misinformation, according to Stacy Loeb, MD, MSc, PhD (Hon), and colleagues.
Q&A: Clinical Trials at the Summit explores new data in vitreoretinal diseases

2 days ago | healio.com | Anthony DeFino |Arshad Khanani

Key takeaways: The meeting will take place June 21 in Las Vegas. Attendees will explore topics such as regulatory considerations for pivotal trial design and AI in imaging and clinical development. Clinical Trials at the Summit will be held Saturday, June 21, at Fontainebleau Las Vegas. The meeting will focus on the latest data in vitreoretinal care from ongoing clinical trials.
Trump signs executive order meant to bring down drug prices

2 days ago | healio.com | Stephen Feller

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
Gastric cancer is increasingly diagnosed at early, more treatable stages

2 days ago | healio.com | Matthew Shinkle

Key takeaways: Over the past 2 decades, detection of early-stage gastric cancer has increased by more than 50%. This finding may be attributed to improved endoscopic imaging and increased utilization of upper endoscopy. SAN DIEGO — Detection of early-stage gastric cancer has become more common over the past 2 decades, while diagnosis of advanced-stage disease has been steadily declining, according to data presented at Digestive Disease Week.
VIDEO: Dexamethasone implant shows positive results in DME after anti-VEGF treatment

2 days ago | healio.com | Baruch D. Kuppermann |Anthony DeFino

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Baruch D. Kuppermann, MD, PhD, shares positivedata on the dexamethasone intravitreal implant for diabetic macular edema. The retrospective analysis included 167 patients with a suboptimal response to anti-VEGF treatment. “We either continued them on standard-of-care anti-VEGF injections or DEX implant was initiated,” he said.